APA (7th ed.) Citation

R, J., L, C., M, T., JG, M., TC, D., & CD, H. (2012). Optimum ribavirin exposure overcomes racial disparity in efficacy of peginterferon and ribavirin treatment for hepatitis C genotype 1. The American journal of gastroenterology, 107(11), 1675. https://doi.org/10.1038/ajg.2012.306

Chicago Style (17th ed.) Citation

R, Jin, Cai L, Tan M, McHutchison JG, Dowling TC, and Howell CD. "Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1." The American Journal of Gastroenterology 107, no. 11 (2012): 1675. https://doi.org/10.1038/ajg.2012.306.

MLA (9th ed.) Citation

R, Jin, et al. "Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1." The American Journal of Gastroenterology, vol. 107, no. 11, 2012, p. 1675, https://doi.org/10.1038/ajg.2012.306.